<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Carcinoembryonic antigen-related cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule 6 (CEACAM6) inhibits anoikis and affects the malignant phenotype of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we analyzed CEACAM6 as a gene that is highly upregulated in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> tissues, and examined the assertion that CEACAM6 might be a suitable candidate <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> marker for the diagnosis of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: CEACAM6 gene expression in human colon tissues was performed by tissue microarray and analyzed using RT-PCR (each of <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue, n=40) and immunohistochemical and clinicopathological (<z:hpo ids='HP_0003003'>colon cancer</z:hpo> patients, n=143) analyses </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: CEACAM6 transcriptional and translational levels were significantly upregulated in human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissues compared to non-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> regions, and clinicopathological analysis revealed a significant correlation between CEACAM6 protein expression and Dukes' stage (p&lt;0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>High expression levels of CEACAM6 were significantly associated with lower overall survival (p&lt;0.001) and shorter recurrence-free survival (p&lt;0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>We demonstrated that knockdown of CEACAM6 with CEACAM6-specific small interfering <z:chebi fb="40" ids="33697">RNA</z:chebi> in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells attenuated invasivity (35%); conversely, the overexpression of CEACAM6 increased invasiveness </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: CEACAM6 is significantly upregulated in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> tissues and is closely associated with poor prognosis, indicating that CEACAM6 might be used as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> biomarker and a potential therapeutic target for <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
</text></document>